| Filed On | Filing |
|---|---|
| 29 Jun 2026 |
Form 3: Marshall Richard Henry, Chief Medical Officer
Holds 30,000 shares of Common Stock |
| 11 Feb 2026 |
Form 3: Stansky Michael P, Director
Holds 543,232 shares of Common Stock |
| 10 Jul 2025 |
Form 3: Patience David, Chief Financial Officer
No securities owned |
| 31 Jan 2025 |
Form 3: Gordon Gary B., Director
No securities owned |
| 31 Jan 2025 |
Form 3: Valle William, Director
No securities owned |
| 15 Jan 2025 |
Form 3: Young James Emmett, Chief Financial Officer
Holds 9,226 shares of Common Stock |
| 07 May 2024 |
Form 3: Hyveled Liselotte, Director
No securities owned |
| 31 Aug 2023 |
Form 3: Devlin Jodi, President, Therapeutics
No securities owned |
| 15 Aug 2023 |
Form 3: Szela Mary T, Director
Holds 279,963 shares of Common Stock |
| 14 Aug 2023 |
Form 3: Von Eschenbach Andrew C., Director
No securities owned |
| 14 Aug 2023 | Form 3: Singhal Anil K., Director |
| 14 Aug 2023 |
Form 3: Martin George Kelly, Director
No securities owned |
| 14 Aug 2023 |
Form 3: Hicks Kerry R, Director
Holds 1,370,028 shares of Common Stock |
| 14 Aug 2023 |
Form 3: Desai Arjun Jj, Director
Holds 203,127 shares of Common Stock |
| 14 Aug 2023 |
Form 3: Stevens Jennifer, Chief Regulatory Officer
Holds 18,031 shares of Common Stock |
| 14 Aug 2023 |
Form 3: Murphy Sean, Director
Holds 357,535 shares of Common Stock |
| 14 Aug 2023 |
Form 3: Marshak Richard, Sr.VP, Corp. Dev. & Strategy
Holds 12,499 shares of Common Stock |
| 14 Aug 2023 |
Form 3: Katz Steven C, Chief Medical Officer
Holds 34,443 shares of Common Stock |
| 14 Aug 2023 |
Form 3: Cox Bryan F., Chief Scientific & Manufact.
Holds 71,944 shares of Common Stock |
| 14 Aug 2023 |
Form 3: Alecxih James, President, Device Technology
Holds 94,754 shares of Common Stock |
Loading...
